Aptevo Therapeutics Inc. (APVO) financial statements (2020 and earlier)

Company profile

Business Address 2401 4TH AVE.
SEATTLE, WA 98121
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments12318155
Cash and cash equivalents1231710
Short-term investments  7445
Restricted cash and investments  0 
Receivables7524
Inventory, net of allowances, customer advances and progress billings6217
Inventory6217
Prepaid expense47  
Other current assets047 
Other undisclosed current assets  46
Total current assets:30499571
Noncurrent Assets
Operating lease, right-of-use asset4
Property, plant and equipment4566
Long-term investments and receivables   (3)
Accounts and financing receivable, after allowance for credit loss   (3)
Intangible assets, net (including goodwill)45615
Intangible assets, net (excluding goodwill)45615
Restricted cash and investments7710 
Other noncurrent assets41  
Other undisclosed noncurrent assets   3
Total noncurrent assets:23192220
TOTAL ASSETS:536711792
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4454
Employee-related liabilities4454
Debt20 3 
Deferred revenue and credits 1
Other liabilities113 
Other undisclosed current liabilities1413715
Total current liabilities:38181920
Noncurrent Liabilities
Long-term debt and lease obligation3191618
Long-term debt, excluding current maturities 191618
Operating lease, liability3
Liabilities, other than long-term debt 013
Deferred revenue and credits 3
Other liabilities 010
Total noncurrent liabilities:3191622
Total liabilities:42373541
Stockholders' equity
Stockholders' equity attributable to parent, including:12308251
Common stock0000
Additional paid in capital180158156151
Accumulated other comprehensive loss  (0)(0)
Accumulated deficit(168)(127)(74)(81)
Other undisclosed stockholders' equity attributable to parent   (20)
Total stockholders' equity:12308251
TOTAL LIABILITIES AND EQUITY:536711792

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues32231536
Revenue, net1536
Cost of revenue
(Cost of Goods and Services Sold)
(20) (5)(24)
Gross profit:12231012
Operating expenses(55)(64)(64)(139)
Other undisclosed operating loss (11)  
Operating loss:(43)(52)(54)(127)
Nonoperating income (expense)2(2)(2)(1)
Investment income, nonoperating4   
Other nonoperating expense(2)(2)(2)(1)
Interest and debt expense(0)   
Loss from continuing operations before equity method investments, income taxes:(40)(54)(56)(128)
Other undisclosed loss from continuing operations before income taxes(4)   
Loss from continuing operations before income taxes:(45)(54)(56)(128)
Income tax benefit  2315
Loss from continuing operations:(45)(54)(33)(112)
Income from discontinued operations4 40 
Net income (loss) available to common stockholders, diluted:(40)(54)7(112)

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net income (loss):(40)(54)7(112)
Comprehensive income (loss):(40)(54)7(112)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent 0(0)(0)
Comprehensive income (loss), net of tax, attributable to parent:(40)(54)7(112)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: